BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 12078851)

  • 1. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
    Leyden JJ
    Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study.
    Leyden J; Kaidbey K; Levy SF
    Am J Clin Dermatol; 2001; 2(4):263-6. PubMed ID: 11705253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
    Gans EH; Kligman AM
    J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of antibiotic resistance in Propionibacterium acnes.
    Leyden J; Levy S
    Cutis; 2001 Feb; 67(2 Suppl):21-4. PubMed ID: 11236211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
    Leyden JJ; Wortzman M; Baldwin EK
    Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.
    Tschen EH; Katz HI; Jones TM; Monroe EW; Kraus SJ; Connolly MA; Levy SF
    Cutis; 2001 Feb; 67(2):165-9. PubMed ID: 11236229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
    Kircik L
    Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
    Bowman S; Gold M; Nasir A; Vamvakias G
    J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
    Leyden JJ
    J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
    Warner GT; Plosker GL
    Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris.
    Tschen E
    Cutis; 2001 Feb; 67(2 Suppl):25-7. PubMed ID: 11236212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutibacterium acnes persists despite topical clindamycin and benzoyl peroxide.
    Heckmann N; Heidari KS; Jalali O; Weber AE; She R; Omid R; Vangsness CT; Rick Hatch GF
    J Shoulder Elbow Surg; 2019 Dec; 28(12):2279-2283. PubMed ID: 31471244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.
    Breneman D; Savin R; VandePol C; Vamvakias G; Levy S; Leyden J
    Int J Dermatol; 2004 May; 43(5):381-7. PubMed ID: 15117375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.